Observational studyEuropean radiology2026
Body composition's effect on the bone-vascular axis of osteoporosis discovered in AI-based CT analysis of COPD patients.
Observational study in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThis study aimed to investigate the effect of body composition on the inverse relationship between vertebral bone density (T12 BMD) and total thoracic vascular calcification (TTVC) in patients with chronic obstructive pulmonary disease (COPD). Moreover, we aimed to assess whether intermuscular adipose tissue (IMAT) affects the bone-vascular axis. MATERIALS AND
methodsChest CT scans of 539 COPD patients from the multicentric prospective COSYCONET study were retrospectively analyzed using AI-based tools for T12 BMD, TTVC, and volumetric body composition. Multivariable linear regression models were built to investigate the effect of conventional body phenotypes (normal, sarcopenic, non-sarcopenic obesity, and sarcopenic obesity). Stepwise interaction model building included T12 BMD, IMAT, their interaction, adding BMI, clinical and metabolic covariates, lung function, physical performance, and age.
resultsThe T12 BMD showed a consistent inverse association with TTVC in all phenotypes, with β = -0.38 (p < 0.01) in normal nutritional status, β = -0.36 (p < 0.01) in sarcopenia, and β = -0.24 (p < 0.01) in non-sarcopenic obesity. However, the phenotype's significant effect was not confirmed in the interaction model. Age and pack-years were associated with calcification, but IMAT remained independently associated (β = 0.15, 95% CI 0.015-0.28, p = 0.029), while the interaction between T12 BMD and IMAT lost significance once age was included.
conclusionIMAT index was independently associated with TTVC in COPD. The modifying effect of IMAT on the bone-vascular axis was most evident in models without age adjustment, suggesting that the observed interaction may be influenced by age. KEY POINTS: Question The interactions between body composition, sarcopenia, arteriosclerosis, and osteoporosis are not fully understood. AI-based CT analysis provides a more holistic picture of multimorbidity in COPD. Findings Intermuscular adipose tissue (IMAT) was independently associated with vascular calcification in stepwise-adjusted models. The interaction of IMAT and bone density is demonstrated but showed age-dependence. Clinical relevance Increased IMAT can capture a vulnerable COPD patient group with metabolic dysregulation and physical frailty, besides vascular aging. Muscle fat infiltration may indicate impaired musculoskeletal health and serve as a marker of arteriosclerosis beyond possible effects of age or BMI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.